Recall: D-1080-2017

Class II - Potentially Harmful

Class IIClassification

2017-07-26Initiated

TerminatedStatus

HOSPIRA INC, LAKE FORESTFirm

Product

Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: Teva Parenteral Medicines, Inc., Irvine, CA 92618 USA. NDC: 0703-0018-01

Reason

Presence of Particulate Matter: Silicone oil

Distribution

Nationwide in the USA

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.